If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Inluriyo ™ (imlunestrant) tablets
200 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How should Inluriyo® (imlunestrant) be administered?
The recommended dosage of Inluriyo (imlunestrant), as monotherapy or in combination with abemaciclib, is 400 mg orally once daily, taken at approximately the same time every day.
Imlunestrant Dosing and Administration
Recommended Imlunestrant Dosing represents the recommended imlunestrant dosing.
Figure 1 description: The recommended dosage of imlunestrant, as monotherapy or in combination with abemaciclib, is 400 mg orally once daily, taken at approximately the same time every day.
Refer to the Prescribing Information for the recommended dosage of abemaciclib when used in combination with imlunestrant.1
Continue treatment until disease progression or unacceptable toxicity.1
Patients should take imlunestrant on an empty stomach at least 2 hours before or 1 hour after food.1
Patients should swallow the tablets whole. Do not split, crush, or chew the tablets.1
If vomiting occurs, the patient should take the next dose of imlunestrant the following day at the scheduled time.1
Guidance for managing missed doses of imlunestrant is illustrated in Management of Missed Doses of Imlunestrant.
Figure 2 description: If a dose of imlunestrant is missed by 6 or more hours, skip the dose and take the next dose the following day at the scheduled time.
Enclosed Prescribing Information
Reference
1Inluriyo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2026.
Date of Last Review: May 14, 2026